Daiichi Sankyo submits a New Drug Application in Japan for the antiplatelet agent prasugrel
18 June 2013 | By Daiichi Sankyo
The application is based on the results of a phase 3 trial...
List view / Grid view
News
Sanofi to present new clinical data at the American Diabetes Association 73rd Scientific Sessions
18 June 2013 | By Sanofi
"an important opportunity for Sanofi to share significant data..."
AstraZeneca selects location for new global R&D centre and corporate headquarters in Cambridge, UK
18 June 2013 | By AstraZeneca
"AstraZeneca’s investment is excellent news for the UK life sciences industry..."
Johnson & Johnson announces definitive agreement to acquire Aragon Pharmaceuticals, Inc.
17 June 2013 | By Johnson & Johnson
Late-stage prostate cancer treatment strengthens oncology pipeline...
Gilead announces interim Phase 2 data for Idelalisib
17 June 2013 | By Gilead Sciences, Inc.
Gilead Sciences announced interim results from a single-arm, open-label Phase 2 study evaluating idelalisib...
New long-term data reinforce safety profile of Pradaxa® for stroke prevention in AF
17 June 2013 | By Boehringer Ingelheim
New long-term data from the RELY-ABLE® study...
Teva strengthens respiratory franchise with acquisition of MicroDose Therapeutx
17 June 2013 | By Teva Pharmaceutical Industries Ltd.
Teva has entered into a definitive agreement to acquire MicroDose Therapeutx...
Any Assay, Any Wavelength, Any Bandwidth with the new CLARIOstar® high performance microplate reader
17 June 2013 | By BMG LABTECH
Over the years, many different assays have been designed...
MedImmune and NGM Biopharmaceuticals announce agreement
17 June 2013 | By AstraZeneca
MedImmune and NGM Biopharmaceuticals have entered into an exclusive agreement...
Three Scientists to receive prestigious Novartis Prizes for Immunology at 15th International Congress of Immunology
17 June 2013 | By Novartis
The Novartis Prizes for Immunology are awarded to three scientists...
Roche’s Avastin approved in Japan for treatment of the most aggressive form of brain cancer
17 June 2013 | By Roche
First approval of Avastin for the treatment of newly diagnosed glioblastoma...
Drug Jakavi® improved overall survival of myelofibrosis patients and impacted an underlying mechanism of disease
16 June 2013 | By Novartis
Results from a Phase III three-year follow-up study...
FDA approves Amgen’s XGEVA® (denosumab) for the treatment of giant cell tumor of bone
13 June 2013 | By Amgen
XGEVA becomes first FDA-approved treatment for this rare disease...
Boehringer Ingelheim’s investigational all-oral interferon-free combination achieved 95% viral cure rates in genotype-1b hepatitis C patients
13 June 2013 | By Boehringer Ingelheim
Data from interferon-free SOUND-C3 study...
Roche’s RoACTEMRA shows long-term efficacy in monotherapy and also benefits in early rheumatoid arthritis
13 June 2013 | By Roche
Roche announced data from two phase III studies...
